Xponance, Inc. Roivant Sciences Ltd. Transaction History
Xponance, Inc.
- $10.1 Billion
- Q1 2025
A detailed history of Xponance, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Xponance, Inc. holds 49,264 shares of ROIV stock, worth $553,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,264
Previous 49,319
0.11%
Holding current value
$553,727
Previous $583,000
14.75%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$740 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$695 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$517 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$458 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$404 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.92B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...